Obesity, overweight at diagnosis ups B-cell lymphoma prognosis

Obesity, overweight at diagnosis ups B-Cell lymphoma prognosis
For U.S. veterans with diffuse large B-cell lymphoma, being overweight or obese at time of diagnosis correlates with improved survival, according to a study published online May 29 in theJournal of Clinical Oncology

(HealthDay) -- For U.S. veterans with diffuse large B-cell lymphoma (DLBCL), being overweight or obese at time of diagnosis correlates with improved survival, according to a study published online May 29 in theJournal of Clinical Oncology

To investigate the association between(BMI) at diagnosis and overall survival, Kenneth R. Carson, M.D., from the St. Louis Veterans Affairs Medical Center, and colleagues conducted ainvolving 2,534 U.S. veterans diagnosed with DLBCL from 1998 to 2008.

The researchers found that the mean age at diagnosis was 68 years, and 64 percent of patients were overweight or obese. Compared with other BMI groups, obese patients were significantly younger, had significantly fewer B symptoms, and showed a trend toward lower-stage disease. Compared with normal-weight patients, Cox analysis showed decreased mortality for overweight and obese patients (hazard ratios, 0.73 and 0.68, respectively). Treatment during the rituximab era attenuated thebut did not impact the association between BMI and survival. One year before diagnosis, disease-related weight loss occurred in 29 percent of patients with weight data, but Cox analysis based on BMI one year before diagnosis showed a persistent association between overweight/obesity and reduced mortality risk.

"Being overweight or obese at the time of DLBCL diagnosis is associated with improved overall survival," the authors write. "Understanding the mechanisms responsible for this association will require further study."

One author disclosed a financial relationship with Genentech.


Explore further

Obesity and overweight linked to higher prostate cancer mortality

更多的信息: Abstract
完整的Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2012HealthDay.All rights reserved.

Citation: Obesity, overweight at diagnosis ups B-cell lymphoma prognosis (2012, May 30) retrieved 4 June 2022 from //www.pyrotek-europe.com/news/2012-05-obesity-overweight-diagnosis-ups-b-cell.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
shares

Feedback to editors